Leveraging Innovative Financing Strategy to Increase Coverage and Resources Among Informal Sector for Social Health Insurance Within the Nigerian Context of Devolution: Evidence From Adoption Model Implementation
Abstract:BackgroundEnrollment in sub-national social health insurance schemes (SSHIS) can be challenging in developing countries like Nigeria, particularly among people in the informal sector. This could be due to a lack of knowledge on its mode of operation and benefits, distrust in government, inimical religious and traditional beliefs, as well as constraining economic factors. A complementary and innovative financing strategy such as the philanthropist adoption model (ADM) could be beneficial in improving SSHIS cove… Show more
“…Altruistic WTP could inform the design of a sliding scale premium in social health insurance schemes that ensure wealthier people pay more for services than less wealthy people [ 39 ]. The NHIA could also promote altruistic payment for haemodialysis by leveraging the adoption model in which altruistic individuals adopt people experiencing poverty and pay their annual social health insurance premium [ 40 ]. Evaluation of altruistic WTP for the entire population is warranted to ensure evidence informs the adoption model for haemodialysis.…”
Background
Evidence of willingness to pay for kidney replacement therapy is scarce in low-middle-income countries, including Nigeria’s Formal Sector Social Health Insurance Programme. The study, therefore, assessed the willingness to pay for haemodialysis among chronic kidney disease patients in Abuja, Nigeria.
Methods
The study adopted a cross-sectional survey design. We used the contingent valuation method to estimate the maximum stated willingness to pay (WTP) for haemodialysis among end-stage kidney disease (ESKD) patients. We obtained informed written consent from respondents before data collection. The socio-demographic characteristics and willingness to pay data were summarized using descriptive statistics. We evaluated the mean differences in respondents’ WTP using Mann-Whitney and Kruskal-Wallis tests. All variables that had p < 0.25 in the bivariate analysis were included in the Generalized Linear Model (gamma with link function) to determine the predictors of the WTP for one’s and another’s haemodialysis. The level of significance in the final model was ρ < 0.05.
Results
About 88.3% and 64.8% of ESKD patients were willing to pay for personal and altruistic haemodialysis, correspondingly. The mean annual WTP for haemodialysis for one’s and altruistic haemodialysis was USD25,999.06 and USD 1539.89, respectively. Private hospital patients were likelier to pay for their haemodialysis (β = 0.39, 95%CI: 0.21 to 0.57, p < 0.001). Patients attending public-private partnership hospitals were less likely to pay for altruistic haemodialysis than those attending public hospitals (β = -1.65, 95%CI: -2.51 to -0.79, p < 0.001).
Conclusions
The willingness to pay for haemodialysis for themselves and others was high. The type of facility ESKD patients attended influenced their willingness to pay for haemodialysis. The findings highlight the need for policies to enhance affordable and equitable access to haemodialysis in Nigeria through pre-payment mechanisms and altruistic financing strategies.
“…Altruistic WTP could inform the design of a sliding scale premium in social health insurance schemes that ensure wealthier people pay more for services than less wealthy people [ 39 ]. The NHIA could also promote altruistic payment for haemodialysis by leveraging the adoption model in which altruistic individuals adopt people experiencing poverty and pay their annual social health insurance premium [ 40 ]. Evaluation of altruistic WTP for the entire population is warranted to ensure evidence informs the adoption model for haemodialysis.…”
Background
Evidence of willingness to pay for kidney replacement therapy is scarce in low-middle-income countries, including Nigeria’s Formal Sector Social Health Insurance Programme. The study, therefore, assessed the willingness to pay for haemodialysis among chronic kidney disease patients in Abuja, Nigeria.
Methods
The study adopted a cross-sectional survey design. We used the contingent valuation method to estimate the maximum stated willingness to pay (WTP) for haemodialysis among end-stage kidney disease (ESKD) patients. We obtained informed written consent from respondents before data collection. The socio-demographic characteristics and willingness to pay data were summarized using descriptive statistics. We evaluated the mean differences in respondents’ WTP using Mann-Whitney and Kruskal-Wallis tests. All variables that had p < 0.25 in the bivariate analysis were included in the Generalized Linear Model (gamma with link function) to determine the predictors of the WTP for one’s and another’s haemodialysis. The level of significance in the final model was ρ < 0.05.
Results
About 88.3% and 64.8% of ESKD patients were willing to pay for personal and altruistic haemodialysis, correspondingly. The mean annual WTP for haemodialysis for one’s and altruistic haemodialysis was USD25,999.06 and USD 1539.89, respectively. Private hospital patients were likelier to pay for their haemodialysis (β = 0.39, 95%CI: 0.21 to 0.57, p < 0.001). Patients attending public-private partnership hospitals were less likely to pay for altruistic haemodialysis than those attending public hospitals (β = -1.65, 95%CI: -2.51 to -0.79, p < 0.001).
Conclusions
The willingness to pay for haemodialysis for themselves and others was high. The type of facility ESKD patients attended influenced their willingness to pay for haemodialysis. The findings highlight the need for policies to enhance affordable and equitable access to haemodialysis in Nigeria through pre-payment mechanisms and altruistic financing strategies.
“…46 support the HIV response in diverse ways, including through the SHI adoption model to pay for coverage of orphans and vulnerable children and poor populations. 47 The model is designed to target a pool of public-spirited individuals with a high net worth to pay premiums for low-income and vulnerable citizens, thereby increasing their access to prepaid health care. 47 A second option is to channel Zakat, a religious contribution, to the HIV Trust fund.…”
Section: Discussionmentioning
confidence: 99%
“…47 The model is designed to target a pool of public-spirited individuals with a high net worth to pay premiums for low-income and vulnerable citizens, thereby increasing their access to prepaid health care. 47 A second option is to channel Zakat, a religious contribution, to the HIV Trust fund. In addition, individuals can donate money for treatment adherence and nutrition support for PLHIV.…”
Section: Discussionmentioning
confidence: 99%
“…Nonetheless, the sustainability of domestic private donations is constrained by its lack of predictability in the amount of funding and lack of stability in terms of funding flow emanating from distrust for government programs. 47,48 Therefore, sustained advocacy and sensitization are required to improve the buy-in of philanthropists.…”
The financial sustainability of the HIV response in Nigeria faces a variety of challenges, including heavy reliance on donor funding that is declining, a low level of domestic funding, and a low level of private-sector financing.n In an effort to improve financing sustainability, integrating HIV testing and treatment services into social health insurance schemes has been slow due to concerns over the high cost of antiretroviral drugs. n Purchasing of HIV treatment and prevention commodities has been inefficient because of the lack of an integrated procurement and supply chain management process.n Despite the high costs associated with providing HIV treatment in hospitals, decentralizing treatment to primary health care centers and shifting tasks to less specialized staff has been slow.
“…Altruistic WTP could inform the design of a sliding scale premium in social health insurance schemes that ensure wealthier people pay more for services than less wealthy people [38]. The NHIA could also promote altruistic payment for haemodialysis by leveraging the adoption model in which altruistic individuals adopt people experiencing poverty and pay their annual social health insurance premium [39].…”
Background
Evidence of willingness to pay for renal replacement therapy is scarce in low-middle-income countries, including Nigeria's Formal Sector Social Health Insurance Programme. The study, therefore, assessed the willingness to pay for haemodialysis among chronic kidney disease patients in Abuja, Nigeria.
Methods The study adopted a cross-sectional survey design. We used the contingent valuation method to estimate the maximum stated willingness to pay (WTP) for haemodialysis among end-stage renal disease (ESRD) patients. The socio-demographic characteristics and willingness to pay data were summarized using descriptive statistics. We evaluated the mean differences in respondents' WTP using Mann-Whitney and Kruskal-Wallis tests. All variables that had p < 0.25 in the bivariate analysis were included in the Generalized Linear Model (gamma with link function) to determine the predictors of the WTP for one's and another's haemodialysis. The level of significance in the final model was ρ < 0.05.
Results About 88.3% and 64.8% of patients receiving haemodialysis were willing to pay for their haemodialysis and others, correspondingly. The mean annual WTP for haemodialysis for one’s and altruistic haemodialysis was USD25,999.06 and USD 1539.89, respectively. Private hospital patients were likelier to pay for their haemodialysis (β = 0.39, 95%CI: 0.21 to 0.57, p < 0.001). Patients attending public-private partnership hospitals were less likely to pay for altruistic haemodialysis than those attending public hospitals (β = -1.65, 95%CI: -2.51 to -0.79, p < 0.001).
Conclusions
The findings highlight the need for policies to promote affordable access to haemodialysis for all socioeconomic groups. Pre-payment mechanisms should be explored rather than out-of-pocket payments which pose financial hardships. The potential for altruistic financing strategies should also inform the redesign of funding policies to enhance equitable access.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.